Cambridge-based AstraZeneca, which is contesting the claims, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'. TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot. The complication – listed as a potential side effect of the jab – has previously been called vaccine-induced immune thrombotic thrombocytopenia (VITT). AstraZeneca's admission could lead to pay-outs on a case-by-case basis. Although accepted as a potential side effect for...